Nutrition

The Supplement Trust Gap: How to Know What's Worth Buying

The supplement market is nearing $100B. Here's a three-step framework to separate credible evidence from marketing noise before you buy.

keedia August 5, 2026 · 7 min read

The Supplement Trust Gap: How to Know What's Worth Buying

The global supplement market is on track to exceed $100 billion in 2026. That number sounds like progress. In practice, it means the gap between credible science and marketing copy has never been wider. For every legitimate finding that reaches consumers, dozens of exaggerated claims arrive first, louder and better funded.

Learning to read supplement evidence isn't just for researchers. It's a practical skill that saves you money, protects your health, and lets you act on the findings that actually matter. Here's a repeatable three-step framework you can apply to any supplement claim, followed by a clear look at what's worth your attention right now.

Why the Noise Is Getting Louder

Supplement companies aren't required to prove efficacy before selling a product in most markets, including the US. The regulatory burden falls on authorities to prove harm after the fact. That structure creates a wide lane for products backed by thin evidence, outdated studies, or findings stretched far beyond their original context.

At the same time, genuinely useful research is being published at a faster rate than ever. Recent studies on creatine, HMB, MSM, melatonin, and B vitamins have produced findings with real relevance for active adults. The problem isn't a lack of good science. It's that good science and bad marketing look identical on a product label.

This is why signal-from-noise literacy matters. You don't need a PhD. You need three questions.

Step 1: What Kind of Study Is This?

Not all evidence is equal. A randomized controlled trial, or RCT, is the gold standard for supplement research. In an RCT, participants are randomly assigned to receive either the supplement or a placebo, and neither group knows which they're getting. That design controls for bias, placebo effect, and confounding variables. When a supplement shows a significant benefit in a well-powered RCT, that's meaningful.

Below RCTs on the evidence ladder, you'll find observational studies, animal studies, and mechanistic studies. Mechanistic research examines how a compound interacts with cells or biological pathways in a lab setting. It's valuable for generating hypotheses. It does not tell you whether taking a supplement will produce a measurable effect in your body.

A useful current example is the emerging research on vitamin B3 and natural killer (NK) cells. A recent study found that B3 metabolites appear to influence NK cell activity, a component of immune function relevant to blood cancers. The headline potential is significant. But the study is mechanistic and early-stage, conducted in subjects with specific blood conditions. It is not a supplementation recommendation for healthy adults. Taking high-dose B3 based on that headline would be running well ahead of the evidence.

The first question to ask about any supplement claim is simply: what type of study produced this finding? If the answer isn't an RCT, treat the claim as preliminary.

Step 2: What Was the Actual Dose?

Study findings are dose-specific. A benefit observed at a particular dose in a controlled trial doesn't automatically apply to the amount in a commercial product, or to a different delivery format. This is one of the most common ways supplement marketing misleads consumers.

Take MSM, methylsulfonylmethane, a sulfur compound increasingly studied for exercise recovery. Research suggests that 1 gram per day may help reduce post-exercise muscle soreness and oxidative stress markers in active adults. That's a specific, clinically tested dose. Many products contain far less, or far more, with different bioavailability profiles. The benefit found in the study belongs to that dose. It doesn't transfer automatically.

The same principle applies to sustained-release melatonin for sleep. Standard immediate-release melatonin at high doses (3mg to 10mg) is widely sold but frequently overshoots what research supports for sleep quality improvement. The evidence for sustained-release formulations at lower doses (0.5mg to 2mg) is more aligned with how the body's melatonin system actually functions. Dose and delivery format both matter. For more on how recovery fundamentals intersect with sleep quality, Recovery Done Right: Basics Beat Gadgets Every Time covers the evidence hierarchy clearly.

Before acting on a study, confirm the dose used in the research matches what you'd realistically consume. If a product doesn't list the exact dose of each active ingredient, that's a red flag. Proprietary blends are a standard way to obscure underdosed formulas.

Step 3: Who Were the Subjects?

Research findings apply most reliably to populations similar to those studied. This sounds obvious, but it's routinely ignored in supplement marketing, which often extrapolates findings from clinical populations to healthy, active adults without any supporting evidence.

Returning to the B3 and NK cell research: the subjects in that study had blood cancers or related conditions that alter immune function in clinically significant ways. The biological context in which B3 affected NK cell activity is fundamentally different from the context of a healthy 35-year-old looking to support immune function. The population gap matters.

Conversely, HMB (beta-hydroxy beta-methylbutyrate) offers an example where population match significantly affects how you interpret the evidence. HMB has the strongest support for muscle preservation in older adults and in individuals experiencing significant muscle loss, such as those in caloric deficit or recovering from injury. Its effects on muscle protein synthesis in already well-nourished, resistance-trained adults are more modest. If you're a healthy adult eating sufficient protein, HMB's impact may be marginal. If you're 65 and managing age-related muscle loss, the evidence is more directly relevant. For context on protein adequacy in active adults, How Much Protein Do You Actually Need Based on Your Activity Level? is a useful reference point before adding any muscle-support supplement.

Ask yourself: were the study subjects like me in terms of age, health status, training level, and baseline nutrition? If the gap is large, the findings require significant caution before applying them to your own routine.

What Currently Clears All Three Bars

Applying these three filters, study design, dose specificity, and population match, significantly narrows the list of supplements with credible support for generally healthy, active adults. Here's where the evidence stands as of 2026:

  • Creatine monohydrate remains the most robustly studied performance supplement available. RCT evidence supports benefits for strength, power output, and muscle mass across a wide population range. Emerging RCT-level research now also suggests benefits for mood and depressive symptoms, with proposed mechanisms involving brain energy metabolism. Effective dose: 3 to 5 grams per day. Population match: broad, including active adults, older adults, and individuals with mood disorders.
  • Sustained-release melatonin at low doses (0.5mg to 2mg) has credible RCT support for improving sleep onset and sleep quality, particularly in individuals with circadian disruption. For active adults where recovery is a performance variable, this has practical relevance. Recovery Is Now a Longevity Strategy, Not an Afterthought offers broader context on why sleep quality is a non-negotiable pillar of long-term performance.
  • HMB clears the bars specifically for adults over 50, those in significant caloric deficit, or individuals managing muscle wasting. For younger, well-nourished, resistance-trained adults, the evidence is less compelling and creatine remains a better-evidenced choice.
  • MSM at 1 gram per day has emerging RCT support for reducing exercise-induced muscle soreness and oxidative stress. It's not a performance enhancer. It's a recovery aid with a specific dose and a reasonably well-matched population in the studies. If your goal is faster recovery between sessions, this one holds up under scrutiny.

Several supplements commonly found in the same product categories do not clear all three bars for healthy active adults in 2026. These include high-dose B3 for immune support, collagen peptides for muscle mass (evidence is weak in trained populations), and most proprietary "recovery blends" where individual ingredient doses aren't disclosed.

Building a Smarter Supplement Strategy

The three-step framework isn't about cynicism. It's about spending your money and attention on what the evidence actually supports. Supplements that clear all three bars represent a short list. That's fine. A short list of well-evidenced supplements outperforms a cabinet full of marginal ones in every meaningful way.

It's also worth noting that supplementation sits on top of, not in place of, foundational nutrition habits. Healthy dietary fats, adequate protein, and whole food variety provide a baseline that no supplement stack can replicate. For a practical look at how dietary fat quality intersects with performance, Avocado, Healthy Fats, and Performance: What Active Adults Should Know covers the evidence without the noise.

If you're building a training program and want to integrate supplement decisions alongside your exercise and recovery strategy, working with a qualified professional helps you prioritize effectively. 5 Recovery Habits That Actually Extend Your Healthspan is a practical starting point for understanding how supplements fit within a broader evidence-based routine.

The supplement industry will keep growing. The marketing will keep amplifying early-stage findings into confident product claims. Your job isn't to dismiss all of it. It's to ask three questions before you buy: what kind of study, what exact dose, and who were the subjects. That filter won't take long. It will save you from spending money on the noise.